Market Tracker

08/01 7:36am ET

Celgene Corp (NASDAQ:CELG)

87.15
Data as of Jul 31
 -1.19 / -1.35%
Today’s Change
65.76
Today|||52-Week Range
90.50
+3.16%
Year-to-Date

Today’s Trading

Previous close88.34
Today’s open87.87
Day’s range-- - --
Volume4,944,484
Average volume (3 months)4,883,805
Market cap$69.7B
Dividend yield--
Data as of 07/31/2014

Growth & Valuation

Earnings growth (last year)+2.12%
Earnings growth (this year)+23.14%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+19.49%
P/E ratio50.4
Price/Sales10.78
Price/Book12.77

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-1.56-2.49%
ABTAbbott Laboratories-0.74-1.73%
ACTActavis PLC-1.29-0.60%
ABBVAbbVie Inc-1.41-2.62%
Data as of 07/31/2014

Financials

Next reporting dateOctober 23, 2014
EPS forecast (this quarter)$0.95
Annual revenue (last year)$6.5B
Annual profit (last year)$1.4B
Net profit margin22.36%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
Chief Operating Officer &
Executive Vice President
Perry A. Karsen
Corporate headquarters
Summit, New Jersey

Forecasts